No profile data available.
Apollomics, Inc. (APLM) is a healthcare company in the blood cancer treatment drugs industry, based in Foster City, United States, with about 14 full-time employees.
It reported revenue of $8.50 million for fiscal year 2025, and net income of -$10.94 million. Its market capitalization was $62.67 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.
Apollomics reported $8.50 million in revenue for fiscal year 2025.
$62.67 million as of October 9, 2026.
Listed companies of a similar size in the same industry (blood cancer treatment drugs) include Cellectis S.a. (CLLS), Atara Biotherapeutics, Inc. (ATRA), Citius Oncology, Inc. (CTOR), Lite Strategy, Inc. (LITS).